Skip to content
Open access

PepGen: conditional generation of peptides for MHC binding

Aug 2026 · Bioinformatics · Vol 42 · 0 citations · 14 references
Medicine

TL;DR

PepGen provides scalable, motif-constrained MHC II peptide redesign and de novo generation, validated through thorough benchmarks and functional assays.

Abstract

Abstract Motivation Peptide-MHC II binding drives adaptive immunity, yet discovery of novel binder peptides remains challenging due to open binding grooves of MHC-II that accommodate variable-length peptides. While discriminative models perform well, they are unfeasible for generation via enumeration due to vast peptide space (2013≈8×1016 for peptides of length 13 amino acids). Generative AI approaches could accelerate binder design to enable vaccines targeted to particular MHC-II alleles or optimize other peptide chemical properties. Results We introduce PepGen, the first protein language model for MHC II peptide generation building on Generalized Language Modeling. PepGen conditions on alleles, arbitrary partial peptides including putative TCR-interacting motifs, and continuous binding affinity. Across multiple benchmarks including infilling and de novo generation, PepGen outperformed frequency sampling, Gibbs clustering, and autoregressive baselines. Adjusted log-probabilities enable good classification performance. Experimental validation confirmed that the SARS-CoV-2 peptide TEGALNTPKDHIGTR binding the HLA-DQA101:03-DQB106:03 allele can be redesigned to bind the HLA-DQA101:02-DQB105:02 allele. PepGen generated three putative TCR-motif-preserving binders gaining up to 70% of original MFI. Overall, PepGen provides scalable, motif-constrained MHC II peptide redesign and de novo generation, validated through thorough benchmarks and functional assays. Availability and implementation Code and Data are available at https://github.com/DaniTheOrange/PepGen.

Read PDF

Similar papers

Open access Aug 2026

CALFP-MHC: Interpretable Pan-Allelic Prediction of Peptide-MHC Binding and Presentation Using Chemically Grounded Fingerprints and Contrastive Learning

CALFP-MHC demonstrates that grounding residue representations in molecular chemistry, rather than sequence symbols alone, improves both robustness and interpretability in peptide–MHC binding prediction.

My-Diem Nguyen Pham, T. Ho, H. Nguyen et al. · 0 citations
Open access Oct 2026

PREpiBind: Protein Representation-integrated Epitope–MHC Class II Binding Prediction

Motivation Accurate peptide–MHC class II (pMHC-II) binding prediction is complicated by MHC polymorphism and context-dependent peptide recognition. Protein representations are usually evaluated in different pipelines, obscuring their contribution to predictive performance. Results We present PREpiBind, a joint-attentio...

D.-K. Jang, Dongwoo Kim, Untaek Hwang et al. · 0 citations
Open access Aug 2026

Peptide-HLA II interaction prediction for post-translationally modified peptides

PepChem, a deep learning model utilizing novel, molecular-level peptide representations that enable predictions for sidechain modifications, bridges the critical gap in PTM-aware immune recognition prediction, with immediate applications in autoimmunity, cancer, and infectious disease.

A. Dumitrescu, Dani Korpela, Adrian M. Bebenek et al. · 0 citations
Open access Sep 2026

Fast-Dissociating High-Supply Peptides as Contributors to MHC-I Antigen Presentation

The major histocompatibility complex class I (MHC-I) immunopeptidome is dynamic and determined by numerous biochemical and cellular features. Computational tools to predict peptide–MHC-I binding focus on the affinity of a specific peptide–MHC interaction; separate tools predict complex stability or presentation. Method...

Om Gandhi, M. Bryan, M. Sim et al. · 0 citations
Open access Sep 2026

An interpretable peptide–HLA model emergently learns binding energetics and structure

The range of peptides a human leukocyte antigen (HLA) binds and displays modulates immune response and therefore underpins vaccine design, neoantigen discovery, autoimmunity, transplantation, and hypersensitivity reactions. Modern predictors of peptide–HLA (pMHC) binding and presentation are remarkably accurate, but th...

Sully F. Chen, Robert J. Steele, E. Oermann · 0 citations
Open access Sep 2026

Beyond natural amino acids: extending immunogenicity risk assessment to modified peptides through chemical feature encoding. A case study on citrullination

Introduction Peptide therapeutics are increasingly explored to treat challenging diseases, but immunogenicity risks limit their clinical success. In silico tools enable immunogenicity screening through prediction of peptide-MHCII binding, yet current methods do not account for chemical properties of non-natural amino a...

M. Cairoli, Morten Nielsen, Catherine J. Betts et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.